Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03835585 · ClinicalTrials.gov registry record · NA

Gun Locks in Firearm Suicide Intervention

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03835585: Completed NA study, sponsored by Florida State University.

NCT03835585 is a NA study that has completed, run by Florida State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03835585, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This study compares the effectiveness of two interventions for suicide over the course of a month. The experimental intervention includes the provision of a gun lock with video instructions, in addition to standard suicide risk interventions (i.e., standardized full suicide risk assessment, safety planning, and lethal means counseling). The comparison intervention group will receive the same standard suicide risk interventions without the gun lock and video. The targeted outcome will be level of engagement in gun safety behaviors (e.g., using a gun lock, using a gun safe, considering getting rid of guns). It is predicted that the experimental intervention will result in greater increases over time in engagement in gun safety behaviors, as compared to the comparison intervention.

Primary Outcome

This includes a variety of actions and thinking patterns that promote safety regarding firearms. This is measured by a self-report instrument (Engagement in Firearm Safety Behaviors; Stanley, 2018), which contains 34 items. The items are scored on a Likert scale (i.e., 0 = Never; 1 = Sometimes, 2 = Often, 3 = Always) to gauge frequency of engagement. 16 items represent behaviors (e.g., "using a gun lock," "trading in your guns") and 18 represent thoughts (e.g., "thought about obtaining a gun loc

Interventions

  • BEHAVIORAL Safety Planning
  • DEVICE Gun lock
  • OTHER Suicide Risk Assessment
  • BEHAVIORAL Lethal Means Counseling

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-11-01
Est. Completion 2022-04-02
Phase NA
Florida State University

219 total trials

What the finished NCT03835585 record still lists

NCT03835585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 4 interventions - of which Safety Planning is the first listed.

NCT03835585 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03835585 about?

NCT03835585 is a clinical study titled "Gun Locks in Firearm Suicide Intervention". This study compares the effectiveness of two interventions for suicide over the course of a month. The experimental intervention includes the provision of a gun lock with video instructions, in addition to standard suicide risk interventions (i.e., standardized full suicide risk assessment, safety p...

What is the current status of trial NCT03835585?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-11-01. Estimated completion is 2022-04-02.

What interventions are being tested in trial NCT03835585?

The interventions under investigation include: Safety Planning (BEHAVIORAL), Gun lock (DEVICE), Suicide Risk Assessment (OTHER), Lethal Means Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT03835585?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03835585's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03835585, the US trial registry maintained by the National Library of Medicine. NCT03835585 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.